Ensysce Biosciences Inc. (ENSC)
NASDAQ: ENSC
· Real-Time Price · USD
2.08
0.02 (0.97%)
At close: Aug 15, 2025, 3:59 PM
2.09
0.64%
After-hours: Aug 15, 2025, 05:36 PM EDT
Ensysce Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 6.04M | 6.22M | 5.21M | 4.42M | 1.44M | 1.75M | 2.23M | 3.15M | 2.99M | 2.71M | 2.52M | 2.72M | 3.65M | 3.88M | 3.53M | 2.31M | 1.94M | 1.49M |
Cost of Revenue | 5.49M | 6.44M | 7.22M | 5.65M | 5.87M | 6.57M | 7.59M | 11.8M | 14.64M | 18.3M | 19.65M | 15.39M | 12.35M | 7.51M | 4.66M | 2.56M | 1.14M | 745.68K |
Gross Profit | 549.21K | -215.79K | -2.01M | -1.23M | -4.44M | -4.82M | -5.36M | -8.65M | -11.64M | -15.6M | -17.13M | -12.67M | -8.71M | -3.62M | -1.13M | -1.41M | -356.77K | 1.41M |
Operating Income | -6.65M | -6.85M | -6.73M | -6.31M | -9.66M | -10M | -10.72M | -13.76M | -17.22M | -21.98M | -24.22M | -20.03M | -30.75M | -24.11M | -19.83M | -18.92M | -2.44M | -1.88M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 70.88K | 1.19M | 1.19M | 1.19M | 1.12M | n/a | n/a | 229.00 | 229.00 | 2.07K | 2.07K |
Pretax Income | -6.58M | -6.82M | -7.99M | -7.93M | -11.28M | -11.55M | -10.63M | -12.6M | -19.77M | -25.45M | -24.21M | -28.77M | -36.11M | -29.14M | -29.11M | -19.05M | -300.66K | -48.66K |
Net Income | -6.58M | -6.82M | -7.99M | -7.93M | -11.28M | -11.54M | -10.61M | -12.6M | -19.74M | -25.51M | -24.99M | -29.54M | -36.87M | -29.8M | -29.05M | -18.79M | -59.01K | 173K |
Selling & General & Admin | 4.76M | 4.75M | 4.72M | 5.08M | 5.23M | 5.18M | 5.36M | 5.12M | 5.58M | 6.38M | 7.1M | 7.36M | 22.04M | 20.49M | 18.71M | 17.51M | 1.48M | 1.37M |
Research & Development | 9.3M | 8.33M | 7.22M | 5.65M | 5.87M | 6.57M | 7.59M | 11.8M | 14.64M | 18.3M | 19.65M | 15.39M | 12.35M | 7.51M | 4.65M | 3.72M | 2.89M | 3.83M |
Other Expenses | -1.69M | -2.64M | -3.42M | -3.42M | -3.64M | -3.18M | -3.19M | -4.63M | -2.99M | -2.71M | -2.52M | -2.72M | -3.65M | -3.88M | -3.53M | -2.31M | -1.94M | -3.32M |
Operating Expenses | 12.37M | 10.44M | 8.52M | 7.31M | 7.46M | 7.41M | 8.6M | 6.12M | 6.58M | 7.39M | 7.1M | 7.36M | 22.04M | 20.49M | 18.51M | 18.15M | 2.18M | 1.65M |
Interest Expense | 15.51K | 46.23K | 1.29M | 1.62M | 1.63M | 1.6M | 353.94K | 61.01K | 58.22K | 96K | 109.52K | 1.49M | 2.01M | 2.88M | 3.21M | 2.03M | 1.72M | 1.01M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.94M | 13.08M | 11.94M | 10.73M | 11.1M | 11.26M | 11.67M | 15.63M | 18.93M | 23.9M | 26.75M | 22.75M | 34.4M | 27.99M | 23.36M | 21.23M | 4.37M | 5.2M |
Income Tax Expense | 74.00 | 74.00 | n/a | -74 | -74 | -3.4K | -3.33K | -3.33K | -3.33K | n/a | -3.87M | -3.87M | -3.87M | -3.87M | n/a | -1.04M | -1.04M | -1.04M |
Shares Outstanding (Basic) | 2.2M | 1.4M | 1.23M | 2M | 2M | 379.6K | 2.26M | 3.09M | 2.27M | 1.05M | 534.51K | 160.72K | 141.6K | 113.7K | 100.37K | 101.06K | 66.89K | 101.15K |
Shares Outstanding (Diluted) | 2.2M | 1.4M | 1.23M | 659.36K | 2M | 379.63K | 2.26M | 3.09M | 2.27M | 1.05M | 534.51K | 160.73K | 141.62K | 113.7K | 100.37K | 101.07K | 66.89K | 101.15K |
EPS (Basic) | -4.08 | -4.27 | -11.09 | -9.74 | -11.61 | -11.61 | -5.48 | -22.17 | -105.43 | -166.8 | -179.38 | -269.14 | -354.84 | -306.48 | -306.22 | -194.96 | -1.23 | 5.79 |
EPS (Diluted) | -4.08 | -4.27 | -11.09 | -9.74 | -11.61 | -11.61 | -5.48 | -22.17 | -105.43 | -160.94 | -173.52 | -263.28 | -348.95 | -306.45 | -305.55 | -194.8 | -3.4 | 3.62 |
EBITDA | -6.58M | -6.77M | -6.7M | -6.3M | -9.65M | -9.95M | -10.27M | -12.54M | -19.71M | -25.35M | -24.1M | -28.7M | -36.02M | -28.18M | -27.81M | -17.52M | 1.42M | 964.36K |
EBIT | -4.83M | -6.77M | -6.7M | -6.3M | -9.65M | -9.95M | -10.27M | -12.54M | -19.71M | -25.35M | -24.1M | -28.7M | -36.02M | -28.18M | -27.77M | -17.48M | 1.46M | 1.65M |
Depreciation & Amortization | 125.08K | 125K | -1.96M | -91.08K | -112.16K | 2.18M | 4.86M | 4.86M | 4.86M | 2.56M | 152.00 | -37 | -25 | -13 | n/a | 203.00 | 202.00 | 202.00 |